(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AURINIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

AURINIA

ST13

US500000087604400

Class

5, 42

Filing

87604400

Registration

6430761

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

07/27/2026

Classification

Registered

Trademark type

Combined

Nice classes

5, 42

Filing date

09/12/2017

Registration date

07/27/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/27/2021

Last transaction

07/27/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

First use anywhere

2016-12-00

First use in commerce

2016-12-00

Drawing code

3

Owner type

11

Owner location

Victoria, BC, CA

Examiner

DYER, ERIN ZASKODA

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the term "AURINIA" in grey appearing next to a flower with blue, purple, yellow, and pink petals.

Holders and representatives

Holders

Aurinia Pharmaceuticals Inc.

Representatives

Matthew R. Wilmot STOEL RIVES LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

(Based on 44(e)) Pharmaceutical preparations for the treatment of autoimmune disorderskidney disordersopthamalogical disorders and lupus nephritis

Class 42

(Based on 44(e)) (Based on Use in Commerce) Research and development of medicinals and pharmaceuticals

Publications

History of USPTO decisions and trademark events.

42 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/27/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/27/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/11/2021

PUBO

PUBLISHED FOR OPPOSITION

05/11/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/21/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/06/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/06/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/06/2021

ALIE

ASSIGNED TO LIE

04/01/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

03/30/2021

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

12/07/2020

GNSI

INQUIRY TO SUSPENSION E-MAILED

12/07/2020

CNSI

SUSPENSION INQUIRY WRITTEN

12/07/2020

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

11/19/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/13/2020

GNSL

LETTER OF SUSPENSION E-MAILED

05/13/2020

CNSL

SUSPENSION LETTER WRITTEN

05/13/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/14/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/13/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/13/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

10/19/2019

GNSI

INQUIRY TO SUSPENSION E-MAILED

10/19/2019

CNSI

SUSPENSION INQUIRY WRITTEN

10/19/2019

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

09/27/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/25/2019

GNSL

LETTER OF SUSPENSION E-MAILED

02/25/2019

CNSL

SUSPENSION LETTER WRITTEN

02/25/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/01/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/01/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

01/30/2019

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

08/04/2018

GNSI

INQUIRY TO SUSPENSION E-MAILED

08/04/2018

CNSI

SUSPENSION INQUIRY WRITTEN

08/04/2018

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

07/16/2018

ALIE

ASSIGNED TO LIE

07/13/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/16/2017

GNSL

LETTER OF SUSPENSION E-MAILED

12/16/2017

CNSL

SUSPENSION LETTER WRITTEN

12/16/2017

DOCK

ASSIGNED TO EXAMINER

12/15/2017

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/19/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/16/2017

NWAP

NEW APPLICATION ENTERED

09/15/2017

Continuous trademark protection

Get notified about every new filing that threatens AURINIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.